Skip to main content
Equibles

Amundi

Position in TEVA — Teva Pharmaceutical Industries Ltd

CIK 1330387 Paris, I0
Back to TEVA Full portfolio

Position in TEVA

as of Jun 30, 2026 · filed Aug 11, 2026
Position Value
$65,383,418
+$12,200,957 QoQ
Shares Held
1,929,853
+9.3% QoQ
Ownership
0.166%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#59
of 676 holders
Holding Since
Jun 2021
21 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in TEVA Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

Amundi holds $594,123,116 across 28 Drug Manufacturers - Specialty & Generic names. TEVA ranks #3 (11.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ZTS
Zoetis Inc.
 3,988,618 $286,622,087
2 UTHR
UNITED THERAPEUTICS Corp
 219,094 $118,711,701
3 TEVA
Teva Pharmaceutical Industries Ltd
This page 		1,929,853 $65,383,418
4 VTRS
Viatris Inc
 3,269,550 $51,920,453
5 NBIX
Neurocrine Biosciences Inc
 220,463 $37,156,833
6 ALKS
Alkermes plc.
 217,739 $11,409,523
7 LNTH
Lantheus Holdings, Inc.
 82,089 $9,106,952
8 ANIP
Ani Pharmaceuticals Inc
 31,793 $2,631,824

All Filings in TEVA

Export CSV
21 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $65,383,418 1,929,853
2026-03-31 $53,182,461 1,765,686
2025-12-31 $100,781,021 3,229,126
2025-09-30 $24,587,681 1,217,212
2025-06-30 $22,180,569 1,323,423
2025-03-31 $10,432,508 678,758
2024-12-31 $12,626,978 572,912
2024-09-30 $11,782,736 653,870
2024-06-30 $10,636,778 654,571
2024-03-31 $7,626,044 540,471
2023-12-31 $4,540,282 434,893
2023-09-30 $5,259,149 515,603
2023-06-30 $3,835,200 509,323
2023-03-31 $3,990,402 450,893
2022-12-31 $3,742,354 410,346
2022-09-30 $3,169,862 392,796
2022-06-30 $2,320,023 308,514
2022-03-31 $2,886,682 307,421
2021-12-31 $2,040,072 254,691
2021-09-30 $2,425,522 249,027
2021-06-30 $2,556,000 258,182